KORU Medical Systems, Inc. — Earnings
Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2025-12-31 | $11M | ↑+23.3% | — | — | — |
| 2025-09-30 | $10M | ↑+27.2% | $-778K | ↑+50.8% | -8.3% |
| 2025-06-30 | $10M | ↑+20.9% | $-207K | ↑+79.1% | -3.1% |
| 2025-03-31 | $10M | ↑+17.5% | $-1M | ↑+39.8% | -12.9% |
| 2024-12-31 | $9M | ↑+23.0% | — | — | — |
| 2024-09-30 | $8M | ↑+16.8% | $-2M | ↓-15.5% | -20.8% |
| 2024-06-30 | $8M | ↑+21.5% | $-989K | ↑+60.4% | -14.1% |
| 2024-03-31 | $8M | ↑+10.9% | $-2M | ↑+19.7% | -23.9% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2025 (Q4)
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Margin trends · 66 quarters
margin trajectory tells the operating-leverage storyGo deeper
KRMD Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyKRMD Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics